领先的数字病理软件提供商Proscia近日宣布，在C+轮融资中成功筹集了900万美元，该轮融资总额达到了4600万美元。本轮融资由Highline Capital Management和Triangle Peak Partners领投，多家现有投资者也参与其中。Proscia计划利用这笔资金加速其商业增长，并进一步开发面向生命科学和诊断实验室的人工智能应用程序。
Proscia的病理学云平台旨在通过AI技术的应用，提高病理学的效率和准确性。该平台能够帮助病理学家更快地分析和诊断疾病，同时减少误诊的可能性。随着医疗行业对精准诊断的需求日益增长，Proscia的AI驱动的病理学云平台有望在未来的医疗领域发挥重要作用。
Proscia的CEO表示，此次融资的成功证明了市场对智能病理解决方案的认可和需求。公司将继续致力于推动病理学的数字化和智能化，为全球的医疗专业人员提供更高效、更精确的工具和服务。
英文标题：Proscia Raises $9 Million to Accelerate AI-Driven Pathology Platform
英文关键词：AI-Driven Pathology, Investment Boost, AI Application Development
英文新闻内容：
Proscia, a leading provider of digital pathology software, has announced the successful closure of a $9 million funding round in its C+ round, bringing the total funding for the round to $46 million. The round was led by Highline Capital Management and Triangle Peak Partners, with participation from existing investors, including Alpha Intelligence Capital, Scale Venture Partners, and Hitachi Ventures. The funds will be used to accelerate Proscia’s commercial growth and further develop its AI applications for life sciences and diagnostic laboratories.
Proscia’s pathology cloud platform leverages AI technology to enhance the efficiency and accuracy of pathology. The platform enables pathologists to analyze and diagnose diseases more quickly and reduce the likelihood of misdiagnosis. As the demand for precise diagnostics grows in the healthcare industry, Proscia’s AI-driven pathology cloud platform is poised to play a significant role in the future of medical diagnostics.
The CEO of Proscia commented that the successful funding round validates the market’s need and recognition for intelligent pathology solutions. The company will continue to focus on advancing the digital
【来源】https://venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
Views: 1